These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15636690)

  • 21. Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.
    Treon SP; Gertz MA; Dimopoulos M; Anagnostopoulos A; Blade J; Branagan AR; Garcia-Sanz R; Johnson S; Kimby E; Leblond V; Fermand JP; Maloney DG; Merlini G; Morel P; Morra E; Nichols G; Ocio EM; Owen R; Stone MJ
    Blood; 2006 May; 107(9):3442-6. PubMed ID: 16410453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHOP plus rituximab therapy in Waldenstrom's macroglobulinemia.
    Treon SP; Hunter Z; Barnagan AR
    Clin Lymphoma; 2005 Mar; 5(4):273-7. PubMed ID: 15794864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fludarabine in Waldenstrom's macroglobulinemia.
    Leblond V; Choquet S
    Semin Oncol; 2003 Apr; 30(2):239-42. PubMed ID: 12720144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging drugs for Waldenström's macroglobulinemia.
    Kastritis E; Terpos E; Dimopoulos MA
    Expert Opin Emerg Drugs; 2011 Mar; 16(1):45-57. PubMed ID: 21352069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire?
    Zinzani PL; Tani M; Alinari L; Stefoni V; Baccarani M
    Leuk Res; 2003 May; 27(5):465-6. PubMed ID: 12620298
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of Waldenström´s macroglobulinaemia in the year 2014].
    Adam Z; Krejčí M; Pour L; Ševčíková E
    Vnitr Lek; 2014 Feb; 60(2):139-57. PubMed ID: 24754419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Waldenström macroglobulinemia.
    Ghobrial IM; Witzig TE
    Curr Treat Options Oncol; 2004 Jun; 5(3):239-47. PubMed ID: 15115652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Waldenström's macroglobulinemia].
    Poulain S; Wemeau M; Balkaran S; Hivert B; Hautecoeur A; Rossignol J; Fernandez J; Daudignon A; Roumier C; Soenen V; Lepelley P; Lai JL; Morel P; Leleu X
    Rev Med Interne; 2010 May; 31(5):385-94. PubMed ID: 20363537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Waldenström's macroglobulinemia with rituximab.
    Dimopoulos MA; Zervas C; Zomas A; Kiamouris C; Viniou NA; Grigoraki V; Karkantaris C; Mitsouli C; Gika D; Christakis J; Anagnostopoulos N
    J Clin Oncol; 2002 May; 20(9):2327-33. PubMed ID: 11981004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone.
    Dimopoulos MA; Tsatalas C; Zomas A; Hamilos G; Panayiotidis P; Margaritis D; Matsouka C; Economopoulos T; Anagnostopoulos N
    Semin Oncol; 2003 Apr; 30(2):265-9. PubMed ID: 12720150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Waldenström's macroglobulinemia.
    McKenna JA
    Clin J Oncol Nurs; 2002; 6(5):283-6. PubMed ID: 12240489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel agents in the treatment of Waldenström's macroglobulinemia.
    Treon SP; Hatjiharissi E; Leleu X; Moreau AS; Roccaro A; Hunter ZR; Soumerai JD; Ciccarelli B; Xu L; Sacco A; Ngo HT; Jia X; Yang C; Adamia S; Branagan AR; Ho AW; Santos DD; Tournilhac O; Manning RJ; Leduc R; O'Connor K; Nelson M; Patterson CJ; Ghobrial I
    Clin Lymphoma Myeloma; 2007 Aug; 7 Suppl 5():S199-206. PubMed ID: 17877845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Waldenström's macroglobulinemia.
    Gertz MA; Fonseca R; Rajkumar SV
    Oncologist; 2000; 5(1):63-7. PubMed ID: 10706651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
    Shaikh A; Habermann TM; Fidler ME; Kumar S; Leung N
    Clin Exp Nephrol; 2008 Aug; 12(4):292-295. PubMed ID: 18288560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fludarabine-based combination therapies for Waldenström's macroglobulinemia.
    Tedeschi A; Alamos SM; Ricci F; Greco A; Morra E
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):67-70. PubMed ID: 19362977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?
    Clavio M; Quintino S; Venturino C; Ballerini F; Varaldo R; Gatto S; Galbusera V; Garrone A; Grasso R; Canepa L; Miglino M; Pierri I; Gobbi M
    J Exp Clin Cancer Res; 2001 Sep; 20(3):351-8. PubMed ID: 11718214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alkylating agents for Waldenstrom's macroglobulinaemia.
    Yang K; Tan J; Wu T
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006719. PubMed ID: 19160296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia.
    Kim HD; Shin KC; Cho HS; Kim MK; Lee KH; Hyun MS
    J Korean Med Sci; 2007 Dec; 22(6):1079-81. PubMed ID: 18162727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapies in Waldenström macroglobulinemia.
    Burwick N; Roccaro AM; Leleu X; Ghobrial IM
    Curr Opin Investig Drugs; 2008 Jun; 9(6):631-7. PubMed ID: 18516762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemia.
    Dimopoulos MA; Zervas C; Zomas A; Hamilos G; Gika D; Efstathiou E; Panayiotidis P; Vervessou E; Anagnostopoulos N; Christakis J
    Clin Lymphoma; 2002 Dec; 3(3):163-6. PubMed ID: 12521393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.